Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

Similar articles for PubMed (Select 8873418)

1.
2.

Correlation of hematopoietic progenitor cell count determined by the SE-automated hematology analyzer with CD34(+) cell count by flow cytometry in leukapheresis products.

Park KU, Kim SH, Suh C, Kim S, Lee SJ, Park JS, Cho HJ, Kim KW, Lee K, Kim HJ, Park J, Joo Min Y, Kim JG, Kim T, Lee JH, Kim SB, Kim SW, Lee KH, Lee JS, Kim WK, Park CJ, Chi HS.

Am J Hematol. 2001 May;67(1):42-7.

PMID:
11279656
3.
4.

Quantification of CD34+ cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays.

D'Hondt L, André M, Guillaume T, Feyens AM, Humblet Y, Doyen C, Bosly A, Dromelet A, Chatelain B, Symann M.

Cytokines Cell Mol Ther. 1997 Mar;3(1):21-6.

PMID:
9287240
5.

Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield.

Díaz MA, Garcia-Sanchez F, Lillo R, Vicent MG, Vicario JL, Madero L.

Haematologica. 1999 Jan;84(1):32-5.

6.
7.

The CD34+ cell concentration in peripheral blood predicts CD34+ cell yield in the leukapheresis product.

Hollingsworth KL, Zimmerman TM, Karrison T, Oliver A, Williams SF.

Cytotherapy. 1999;1(2):141-6.

PMID:
19746591
8.

When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood.

Elliott C, Samson DM, Armitage S, Lyttelton MP, McGuigan D, Hargreaves R, Giles C, Abrahamson G, Abboudi Z, Brennan M, Kanfer EJ.

J Clin Oncol. 1996 Mar;14(3):970-3.

PMID:
8622047
9.

Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization.

Fu P, Bagai RK, Meyerson H, Kane D, Fox RM, Creger RJ, Cooper BW, Gerson SL, Laughlin MJ, Koc ON, Lazarus HM.

Bone Marrow Transplant. 2006 Aug;38(3):189-96.

PMID:
16850032
10.

Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation.

Pérez-Simón JA, Caballero MD, Corral M, Nieto MJ, Orfao A, Vazquez L, Amigo ML, Berges C, González M, Del Cañizo C, San Miguel JF.

Transfusion. 1998 Apr;38(4):385-91.

PMID:
9595022
11.

Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.

Sautois B, Fraipont V, Baudoux E, Fassotte MF, Hermanne JP, Jérusalem G, Bours V, Bosquée L, Schaaf-Lafontaine N, Paulus JM, Sondag D, Fillet G, Beguin Y.

Haematologica. 1999 Apr;84(4):342-9.

12.

Predictive parameters for mobilized peripheral blood CD34+ progenitor cell collection in patients with hematological malignancies.

D'Arena G, Musto P, Di Mauro L, Cascavilla N, Iacono ND, Scalzulli PR, Matera R, Carotenuto M.

Am J Hematol. 1998 Aug;58(4):255-62.

PMID:
9692386
13.

Recruitment of CD34+ cells during large-volume leukapheresis.

Moller AK, Dickmeiss E, Geisler CH, Christensen LD.

J Hematother Stem Cell Res. 2001 Dec;10(6):837-53.

PMID:
11798510
14.

Large volume leukapheresis for collecting hemopoietic progenitors: role of CD 34+ precount in predicting successful collection.

Menichella G, Lai M, Serafini R, Pierelli L, Vittori M, Ciarli M, Rumi C, Puggioni P, Scambia G, Sica S, Leone G.

Int J Artif Organs. 1999 May;22(5):334-41.

PMID:
10467933
15.

Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood progenitor cell collection after G-CSF plus chemotherapy-induced mobilization.

Kozuka T, Ikeda K, Teshima T, Kojima K, Matsuo K, Bessho A, Sunami K, Hiramatsu Y, Maeda Y, Noguchi T, Yamamoto K, Fujii N, Imai T, Takenaka K, Shinagawa K, Ishimaru F, Niiya K, Koide N, Tanimoto M, Harada M.

Transfusion. 2002 Nov;42(11):1514-22.

PMID:
12421227
16.

Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial.

Facon T, Harousseau JL, Maloisel F, Attal M, Odriozola J, Alegre A, Schroyens W, Hulin C, Schots R, Marin P, Guilhot F, Granena A, De Waele M, Pigneux A, Méresse V, Clark P, Reiffers J.

Blood. 1999 Aug 15;94(4):1218-25.

17.

Use of pathology-specific peripheral blood CD34 thresholds to predict leukapheresis CD34 content with optimal accuracy: a bicentric analysis of 299 leukaphereses.

Dobo I, Robillard N, Pineau D, Geneviève F, Piard N, Rapp MJ, Boasson M, Zandecki M, Hermouet S.

Ann Hematol. 2001 Nov;80(11):639-46.

PMID:
11757722
18.

Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells.

de Fabritiis P, Gonzalez M, Meloni G, De Propris MS, Bellucci R, Cordone I, Gozzer M, Leone G, Mandelli F.

Bone Marrow Transplant. 1999 Jun;23(12):1229-36.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk